BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li GQ, Zhang HF. Mad2 and p27 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol 2004; 10(21): 3218-3220 [PMID: 15457580 DOI: 10.3748/wjg.v10.i21.3218]
URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3218.htm
Number Citing Articles
1
Maggie K.-L. Fung, Hiu-Wing Cheung, Hing-Lok Wong, Hiu-Fung Yuen, Ming-Tat Ling, Kowk-Wah Chan, Yong-Chuan Wong, Annie L.-M. Cheung, Xianghong Wang. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumourBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2007; 1773(6): 821 doi: 10.1016/j.bbamcr.2007.03.014
2
W. Brian Dalton, Vincent W. Yang. Mitotic origins of chromosomal instability in colorectal cancerCurrent Colorectal Cancer Reports 2007; 3(2): 59 doi: 10.1007/s11888-007-0001-y
3
Kiyoshi Takagi, Yasuhiro Miki, Yukiko Shibahara, Yasuhiro Nakamura, Akiko Ebata, Mika Watanabe, Takanori Ishida, Hironobu Sasano, Takashi Suzuki. BUB1 Immunolocalization in Breast Carcinoma: Its Nuclear Localization as a Potent Prognostic Factor of the PatientsHormones and Cancer 2013; 4(2): 92 doi: 10.1007/s12672-012-0130-x
4
Lin Li, De-Bin Xu, Xiao-Li Zhao, Tian-Yu Hao. Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancerArchives of Gynecology and Obstetrics 2013; 288(1): 155 doi: 10.1007/s00404-012-2706-7
5
Jacek R. Wiśniewski, Pawel Ostasiewicz, Matthias Mann. High Recovery FASP Applied to the Proteomic Analysis of Microdissected Formalin Fixed Paraffin Embedded Cancer Tissues Retrieves Known Colon Cancer MarkersJournal of Proteome Research 2011; 10(7): 3040 doi: 10.1021/pr200019m
6
Young Hyeh Ko, Ji Hyeon Roh, Young‐Ik Son, Man Ki Chung, Jeon Yeob Jang, Hayoung Byun, Chung‐Hwan Baek, Han‐Sin Jeong. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomasJournal of Oral Pathology & Medicine 2010; 39(4): 349 doi: 10.1111/j.1600-0714.2009.00835.x
7
Yuduo Guo, Peng Huang, Weihai Ning, Hongwei Zhang, Chunjiang Yu. Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics AnalysisJournal of Molecular Neuroscience 2020; 70(11): 1702 doi: 10.1007/s12031-020-01556-1
8
Sudeshna Mukherjee, Sugata Manna, Debolina Pal, Pratima Mukherjee, Chinmay K. Panda. RETRACTED: Sequential loss of cell cycle checkpoint control contributes to malignant transformation of murine embryonic fibroblasts induced by 20‐methylcholanthreneJournal of Cellular Physiology 2010; 224(1): 49 doi: 10.1002/jcp.22089
9
E. Burum‐Auensen, P. M. DeAngelis, A. R. Schjølberg, J. Røislien, O. Mjåland, O. P. F. Clausen. Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancersCell Proliferation 2008; 41(4): 645 doi: 10.1111/j.1365-2184.2008.00539.x
10
E. Ioachim. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological featuresInternational Journal of Clinical Practice 2008; 62(11): 1736 doi: 10.1111/j.1742-1241.2006.01105.x
11
Keun-Yeong Jeong, Minhee Park. Poly adenosine diphosphate-ribosylation, a promising target for colorectal cancer treatmentWorld Journal of Gastrointestinal Oncology 2021; 13(6): 574-588 doi: 10.4251/wjgo.v13.i6.574
12
Caroline Rimkus, Jan Friederichs, Robert Rosenberg, Bernhard Holzmann, Jörg‐Rüdiger Siewert, Klaus‐Peter Janssen. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancerInternational Journal of Cancer 2007; 120(1): 207 doi: 10.1002/ijc.22155
13
Agoston T. Agoston, Pedram Argani, Angelo M. De Marzo, Jessica L. Hicks, William G. Nelson. Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting ComplexThe American Journal of Pathology 2007; 170(5): 1585 doi: 10.2353/ajpath.2007.060779
14
MASANARI MORISHITA, TOSHIYUKI SUMI, YUSUKE NAKANO, MASATOMO TERAMAE, TAKESHI FUKUDA, HIROYUKI NOBEYAMA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancerExperimental and Therapeutic Medicine 2012; 3(2): 341 doi: 10.3892/etm.2011.407
15
Nicholas FS Watson, Lindy G Durrant, John H Scholefield, Zahra Madjd, Duncan Scrimgeour, Ian Spendlove, Ian O Ellis, Poulam M Patel. Cytoplasmic expression of p27<sup>kip1</sup> is associated with a favourable prognosis in colorectal cancer patientsWorld Journal of Gastroenterology 2006; 12(39): 6299-6304 doi: 10.3748/wjg.v12.i39.6299
16
Li Wang, Fang Yin, Yulei Du, Wenqi Du, Bei Chen, Yongguo Zhang, Kaichun Wu, Jie Ding, Jie Liu, Daiming Fan. MAD2 as a Key Component of Mitotic CheckpointAmerican Journal of Clinical Pathology 2009; 131(6): 793 doi: 10.1309/AJCPBMHHD0HFCY8W
17
Heng Wang, Wei Wang, Zhen Wang, Xu Li. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1291859
18
Beth AA Weaver, Don W Cleveland. Does aneuploidy cause cancer?Current Opinion in Cell Biology 2006; 18(6): 658 doi: 10.1016/j.ceb.2006.10.002
19
Espen Burum-Auensen, Paula M. De Angelis, Aasa R. Schjølberg, Katherine L. Kravik, Marit Aure, Ole Petter F. Clausen. Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by ImmunohistochemistryJournal of Histochemistry & Cytochemistry 2007; 55(5): 477 doi: 10.1369/jhc.6A7077.2007
20
YUSUKE NAKANO, TOSHIYUKI SUMI, MASANARI MORISHITA, TAKESHI FUKUDA, HIROYUKI NOBEYAMA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumorsOncology Letters 2012; 3(2): 281 doi: 10.3892/ol.2011.483
21
Alejandro López-Saavedra, Luis A. Herrera. The role of alternative mRNA splicing in chromosome instabilityMutation Research/Reviews in Mutation Research 2010; 705(3): 246 doi: 10.1016/j.mrrev.2010.09.002
22
Mafalda Pinto, Maria J. Soares, Nuno Cerveira, Rui Henrique, Franclim R. Ribeiro, Jorge Oliveira, Carmen Jerónimo, Manuel R. Teixeira. Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changesVirchows Archiv 2007; 450(4): 379 doi: 10.1007/s00428-007-0386-7
23
Tara Byrne, Helen G. Coleman, Janine A. Cooper, W. Glenn McCluggage, Amanda McCann, Fiona Furlong. The association between MAD2 and prognosis in cancer: a systematic review and meta-analysesOncotarget 2017; 8(60): 102223 doi: 10.18632/oncotarget.18414
24
Giorgia Simonetti, Samantha Bruno, Antonella Padella, Elena Tenti, Giovanni Martinelli. Aneuploidy: Cancer strength or vulnerability?International Journal of Cancer 2019; 144(1): 8 doi: 10.1002/ijc.31718
25
Rohini Samadarsi, Linus Augustin, Chandan Kumar, Debjani Dutta. In-silico and in-vitro studies on the efficacy of mangiferin against colorectal cancerBMC Chemistry 2022; 16(1) doi: 10.1186/s13065-022-00835-9
26
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future PerspectivesClinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006
27
Acacia F. Dishman, Francis C. Peterson, Brian F. Volkman. Specific binding‐induced modulation of the XCL1 metamorphic equilibriumBiopolymers 2021; 112(10) doi: 10.1002/bip.23402
28
L Yang, S Feng, Y Yang. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysisCancer Gene Therapy 2016; 23(12): 439 doi: 10.1038/cgt.2016.64